COVID-19 in children with somatic pathology
Authors:
- M. S. RajkovicMRM. S. Rajkovic
- S. B. ChuelovSCS. B. Chuelov
- S. K. PylaevaSPS. K. Pylaeva
- Д. Д. СавельеваДСД. Д. Савельева
- А. А. ChernyshevaАCА. А. Chernysheva
- S. A. TosoevaSTS. A. Tosoeva
- D. D. NamazovaDND. D. Namazova
- J. N. IvanovaJIJ. N. Ivanova
- A. N. SlatetskayaASA. N. Slatetskaya
- A. L. RossinaARA. L. Rossina
- М. A. SayfullinМSМ. A. Sayfullin
- E. E. PetryaykinaEPE. E. Petryaykina
Open Access
- 16 November 2024
- journal article
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (4) , 22-28
Abstract
The coronavirus infection is a pressing issue in modern healthcare, yet the characteristics of the SARS-CoV-2 infection course in children with comorbidities remain insufficiently studied. The aim of this study was to evaluate the clinical form, severity, and duration of SARS-CoV-2 virus shedding in pediatric patients with somatic diseases, depending on the comorbid pathology. Materials and Methods. A comprehensive single-center retrospective study was conducted, analyzing 314 medical records of patients hospitalized in the infectious diseases department of the Russian Children’s Clinical Hospital in Moscow over 11 months in 2022. The inclusion criterion was the presence of a laboratory-confirmed COVID-19 diagnosis. Results. Children with comorbidities were found to be predisposed to a more severe course of SARS-CoV-2 infection compared to the pediatric population in general. Children with hematological diseases were at the highest risk of adverse outcomes from COVID-19. Patients with oncological and hematological diseases and primary immunodeficiencies shed the SARS-CoV-2 virus significantly longer than patients with other somatic pathologies. The duration of SARS-CoV-2 RNA detection in patients with severe COVID-19 was significantly longer, which also correlated with the severity of the underlying somatic disease. Conclusion. Children with comorbidities are at risk for a more severe and prolonged course of SARS-CoV-2 infection.Keywords
This publication has 6 references indexed in Scilit:
- Risk factors for severe COVID-19 in hospitalized children in Canada: A national prospective study from March 2020–May 2021The Lancet Regional Health - Americas, 2022
- COVID-19 and comorbidities in childrenVoprosy praktičeskoj pediatrii, 2022
- The novel coronavirus disease (COVID-19) in children with cancer, hematologic malignancies, and severe immunodeficiencies. Results of monocenter studyPediatric Hematology/Oncology and Immunopathology, 2021
- Underlying Medical Conditions Associated With Severe COVID-19 Illness Among ChildrenJAMA Network Open, 2021
- COVID‐19 in pediatric oncology from French pediatric oncology and hematology centers: High risk of severe forms?Pediatric Blood & Cancer, 2020
- SARS-CoV-2 Infection in ChildrenNew England Journal of Medicine, 2020